PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.\', \'Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Macao, China.\', \'Chinese Medicine Department of the Cancer Hospital of the Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.\', \'State Key Laboratory of Subtropical Silviculture, Department of Traditional Chinese Medicine, Zhejiang A&F University, Hangzhou, China.\', \'Beijing Zhongyan Tong Ren Tang Pharmaceutical R&d Co. LTD, Beijing, China.\', \'Department of Pharmacy, The First Affiliated Hospital of Anhui University of Chinese Medicine, No. 117, Meishan Road, Shushan District, Hefei City, Anhui Province, PR China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1097/MD.0000000000027112
?:doi
?:hasPublicationType
?:journal
  • Medicine
is ?:pmid of
?:pmid
?:pmid
  • 34941025
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.105
?:rankingScore_hIndex
  • 4
is ?:relation_isRelatedTo_publication of
?:title
  • Exploring potential mechanisms of Suhexiang Pill against COVID-19 based on network pharmacology and molecular docking.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34941025>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34941025>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all